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ABSTRACT
Poultry has become especially important to genetic research due to breeding feasibility, short
generation turnover, and ease of maintaining large populations. The discovery of virus induced cancer
has paved the way for further genetic studies. Rous Sarcoma Virus (RSV) is a tumor-causing virus that
infects poultry. While not prevalent today, it can serve as a model for virus-induced cancer in humans and
create additional insight to marker assisted selection in poultry. Genetically selected Arkansas Progressor
(AP) and Arkansas Regressor (AR) chicken lines have been established and maintained at the Arkansas
Experimental Station (AES) in Fayetteville, AR. Previous research has investigated the immunological
and genetic characteristics of virus induced tumors. Publication of the Red Jungle Fowl genome has
made it possible to perform genome wide studies to identify biomarkers associated with the susceptibility
to RSV induced tumors. In this study, whole genomes of AP and AR lines were sequenced and analyzed
using Illumina platform next generation sequencing. Over 9,000,000 SNPs were identified against the
reference genome and 12,000 were classified as unique SNPs between the AR and AP line. Most SNPs
were found in intergenic regions, while few were in protein coding regions. Unique SNPs were
categorized by the following mutations: Frameshift (134), No Start (25), No Stop (7), Non-synonymous
(6884), and Nonsense (112). Unique SNPs were characterized as occurring in only one line. Nine SNPs
were chosen after genomic analyses for testing using PCR and Sanger sequencing in larger populations
of AR and AP birds followed by validation in unrelated populations. No statistical correlations were found
between the 9 SNPs in the unrelated populations, Giant Jungle Fowl (GJF) and White Leghorn (WL). No
genetic difference was detected between birds of differing phenotypes within the GJF and WL lines. SNP
frequencies were the same for both birds that regressed tumors and those that progressed tumors.
Interestingly, it was observed that the GJF line response to RSV resembled the AR line and the WL line
resembled the AP line, and GJF and WL exhibited differing phenotypes, indicating the potential to find
biomarkers in larger population sizes.
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INTRODUCTION
Identifying and understanding the genetic mechanisms by which evolutionary changes occur can
provide insight into the association between the genotypic and phenotypic characteristics of organisms.
Domestic animals serve as excellent models for genetic studies involving phenotypic evolution. Genetic
adaptations have resulted in domestic animals’ evolution under the control of human-driven selection
leading to remarkable phenotypic changes. With the current advancements in molecular genetics, the
identification of genetic markers has provided opportunities to improve conventional selection when the
desired phenotype is not measurable and/or has low heritability (Dekkers, 2003). The studies described in
this thesis will provide beneficial information toward marker-assisted selection.
This thesis will cover, in detail, the genetic basis of the chicken genome responsible for the
regression and progression of tumors caused by RSV. The objective of this study was to analyze whole
genome sequences of genetically selected chicken lines, Arkansas Progressor (AP) and Arkansas
Regressor (AR), retaining commercially and biomedically important traits using next generation
sequencing techniques and bioinformatics tools. Millions of SNPs were identified by genome sequencing
for AP and AR lines and nine candidate genetic markers were tested for further application in unrelated
populations. The main objective of this study was to find direct application of chosen SNPs for both
genetic marker assisted animal selection and diagnosis of human genetic disorders.
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CHAPTER 1: LITERATURE REVIEW
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INTRODUCTION

Next generation sequencing has provided a stepping stone for studies in evolution, genetic
diseases, and medicine. This thesis will demonstrate how the chicken can be used as a model for genetic
investigations. Whole genome sequencing was used to identify potential genetic loci under selection for
tumor progression and regression caused by Rous sarcoma virus (RSV) in chickens. RSV is a cancercausing virus which induces malignant tumors of connective tissue known as sarcomas. Phenotypic data
was collected and analyzed against genotypic data to identify potential markers associated with malignant
sarcomas. In order to collect phenotypic data for the purposes of this study, the chicken was the chosen
model.
BIOMARKER RESEARCH AND APPLICATION

Whole genome re-sequencing using next-generation massively parallel sequencing technologies
greatly contributes to molecular applications in studying genetic variation. Current DNA sequencing
technologies have improved throughput and reduced costs. Genome wide association studies provide
more accurate results in mapping associated loci when compared to the alternative technique, linkage
analysis. One such study identified a region of the chicken genome containing the genes ROBO1 and
ROBO2, which were found to strongly affect antibody response to Newcastle disease in chickens (Luo et
al., 2013). Genetic polymorphisms provide evidence of variations in specific phenotypes such as disease
resistance, response to drugs or the environment, or improved performance (Li et al., 2009). Dekkers et
al. (2007) found that using marker-assisted selection in commercial crossbred chickens increased
performance by 10% and decreased inbreeding from 2.1% to 1.4%. The use of these technologies
allows the discovery of genetic mechanisms that can lead to phenotypic differentiation by identifying
genomic mutations in wide ranges of genomic regions, which have been accumulated under selection
(Johansson et al., 2010).
Whole genome sequencing has also greatly benefited biomedical science in humans. This
advancement enabled scientists to discover biomarkers, which can aid in the diagnosis and prognosis of
certain diseases. Two genes, miRNA-21 and KLK, were discovered to be potential biomarkers associated
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with the response in cancer immunotherapy (Wang, 2013) and prostate cancer prognosis (Batra et al.,
2012), respectively. Today, single nucleotide polymorphisms (SNPs) are being used as candidate
biomarkers which create alternative forms of genotypes. A population containing different genotypes for
one particular loci could create distinct phenotypes causing variation within the population. With
technology continuing to advance, the association between genotypes and their causal phenotypes will
contribute to marker assisted genetic selection and disease diagnosis and prevention.

CHICKEN AS A MODEL FOR GENETIC RESEARCH

The advancement of knowledge in the etiology and pathogenesis of human diseases, including
cancer, heart diseases and various infectious diseases, have been futhered by the use of animal models.
The chicken has a long history in oncology studies, especially those associated with oncogenic viruses
(Calnek, 1992). In the early 1900s, cell-free filtrates were used to transmit leukemias and sarcomas in
chickens (Rous, 1911). More recently, studies with avian luekosis/sarcoma viruses have paved the road
in the first attempts to identify the genetic and molecular basis of viral oncogenesis (Neel et al, 1981).
Research by Rubin (1960) led to the discovery of the resistance-inducing factor (RIF) test for
avian leukosis virus (ALV), which later allowed definition of the epidemiology, pathogenesis and
immunology of lymphoid leukosis (Cooper et al., 1968). From this study, target cells and characteristics of
transformed cells and viruses were investigated in addition to the host-virus interactions. RSV was the
first virus identified to be transmissible in chickens (Weiss et al., 2011). Hanafusa et al. (1964) was able to
discover the ‘src’ oncogene in the chicken genome after Rubin’s finding of RIF. The ‘src’ gene produces a
src

protein which is a 60,000 dalton-phosphoprotein (pp60 ). This protein is necessary for transforming cells
to sarcomas in birds. Sefton et al. (1979) inferred that pp60
src

of tyrosine in pp60

src

is a protein kinase and the phosphorylation

is vital to the RSV induced malignant transformation of cells. The pp60

src

protein was

phosphorylated in the tyrosine residues in both human and chicken cells when examined by
src

immunoprecipitation assay. Moreover, all uninfected vertebrate cells contained pp60 , a homolog of
src

viral pp60

in the host genome, termed as a cellular src (cSRC) and cSRC was characterized as a
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cellular proto-oncogene (Sefton et al., 1986). The prevalence and variety of naturally-occurring sarcomas
in chickens contribute to the validity in using the chicken as a model for tumor and cancer research.

RSV BACKGROUND AND MECHANISM

RSV is in the family Retroviridae and subfamily Orthoretrovirinae which consists of all oncogenic
retroviruses. Oncogenic viruses are further divided into seven genera based on morphology and genome
complexity. The seven genera are divided into simple and complex retroviruses. The simple retroviruses
include alpharetroviruses, betaretroviruses and gammaretroviruses. RSV is an example of a retrovirus in
the genera alpharetrovirus. Simple retrovirus genomes encode three genes: virion capsid/nucleopcapsid
(Gag) proteins responsible for core proteins, Pol genes, which are enzymes to aid in genome replication
(reverse transcriptase and integrase), and envelope (Env) proteins to enable cell infection (Braoudaki et
al., 2011). Reverse transcriptase becomes active upon penetration of the host cell and the virion uncoats.
Primers hybridized to the viral RNA genome are elongated to form a complimentary DNA, and then the
reverse transcriptase removes the parental RNA from the DNA. A second strand of DNA is synthesized to
generate a double-stranded DNA provirus. The provirus integrates itself into host chromosomal DNA
catalyzed by the viral Integrase. When the host cell proliferates, the provirus is replicated along with the
host DNA (Weiss, 1996). If the provirus genome is expressed (transcribed), that cell will transform into a
tumor cell and can proliferate and form a sarcoma.
Sarcomas are solid tumors derived from bone, cartilage, fat, muscle, vascular, or hematopoietic
tissues that can metastasize in any organ of the body (Braoudaki et al., 2011). The study described in this
thesis uses RSV to induce sarcomas in the wing web of a chicken to study genotypic-phenotypic
relationships in the chicken genome to find possible mutations associated with RSV response. Mutations
in host oncogenes can be the cause for the susceptibility to RSV-induced tumors.
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CELLULAR RESPONSE TO VIRUSES

A host cell initially detects a virus using the innate immune system. The innate immune system is
responsible for the first 5 days of immunological activity against a virus. Viruses, such as RSV typically
infect cells through attachment to normal cell surface molecules as receptors, thereby enabling entry into
the innate cell. Receptors of innate cells recognize unique molecular structures expressed by different
classes of infectious organisms. Cells of the innate immunesystem include monocytic cells, dendritic cells
(DC), natural killer (NK) cells, and polymorphonuclear leukocytes (PMN). The innate immune system
mediates a response using preexisting cells to direct and support other protective responses (Shizuo et
al. 2006).
The key mechanism s of the innate system against viruses are inhibiting infection by type I
interferons and NK cell-mediated killing of the infected cells. The production of type I interferons is
triggered by several biochemical pathways. Recognition of viral RNA and DNA by endosomal Toll-like
receptors (TLRs) and activation of cytoplasmic RIG-like receptors by viral RNA is followed by the
convergence of these two pathways on the activation of protein kinases. The protein kinases activate the
IRF (Interferon regulatory factors) transcription factors which in turn stimulate interferon gene transcription
whose products interfere with viral replication. NK cells kill infected cells before the adaptive immune
responses develop. NK cells recognize infected cells in which a virus has turned off class I MHC
expression as a mechanism to escape from cytotoxic T cells (CTLs). The absence of class I MHC
releases NK cells from a normal state of inhibition. The most common CTLs involved in viral infection are
+

CD8 T cells which recognize cytosolic viral peptides presented by class I MHC molecules. The primary
role of CTLs is to kill any infected nucleated cells. The antiviral activity of CTLs comes from killing the
cells but also activating nucleases within infected cells. These nucleases can degrade viral genomes and
secretion of cytokines which can activate phagocytes (Perry et al, 2005). Identification of genetic
mutations housed in genes which produce proteins involved in this process can increase knowledge of
the immune system, in turn contributing to possible advancements in medicine.
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HISTORY OF LINEAGE FOR AR AND AP LINES

The two divergently selected chicken lines used in this study are the Arkansas Regressor (AR)
and Arkansas Progressor (AP) lines. The AR and AP lines were developed from purebred White Leghorn
(WL) and Giant Jungle Fowl (GJF) strains (Gyles et al., 1967). The WL strain was maintained at the
Arkansas Agricultural Experiment Station (AES) in Fayetteville, AR as a small flock, beginning in 1946.
Due to the parental population size, this line is highly inbred but the inbreeding coefficient is unknown.
The GJF strain’s origin stems from one male and five hens and is theorized to be highly inbred also. The
GJF male and five hens were transported to Fayetteville, AR from Southeast Asia in 1951 (Gyles et al.,
1966). GJF line has been maintained at the AES since 1951 as a small closed flock.
In 1964, the chorioallantoic membrane (CAM) of chick embryo was inoculated with RSV of both
the WL and GJF strains. WL was discovered to be highly susceptible to tumor development by
inoculations of RSV (Bower, 1962; Bower et al., 1964) while GJF showed high resistance to tumor
development to inoculations of RSV. These findings led to the development of the AP and AR lines used
in this thesis (Gyles et al., 1967; Bower, 1962; Bower, 1962; Bower et al., 1964). The GJF and the WL
strains were crossed in 1965 to produce the AR line maintained at the AES in Fayetteville, AR. One
reciprocal F1 cross (GJF X WL) was created by the mating of 8 GJF males to 10 WL hens. The other
reciprocal F1 cross (WL X GJF) was created by the mating of 9 WL males to 17 GJF hens. The AP line
consists of only WL paired matings and was created with 13 hens to 10 males (Gyles et al. 1966). All
matings were pedigreed and performed by artificial insemination.

GENETIC RESISTANCE TO RSV: MHC AND NON-MHC GENES

There is a strong association between the chicken Major Histocompatibility Complex (MHC) and
disease caused by small infectious pathogens (Collins et al., 1977). The chicken MHC is composed of
single dominantly expressed genes resulting in decreased peptide recognition by immune receptors. In
the case of genetic resistance to RSV to chickens, the B-F/B-L region of the B locus is the major
determinant of regression and progression of RSV-induced tumors (Kaufman et al., 2000). Gyles et al.

7

(1977) tested this genetic association to MHC by mating chickens selectively based on tumor progression
or tumor regression. The progressor mating line was purebred White Leghorn while the regressor line
was comprised of White Leghorn and Giant Jungle Fowl (GJF) and their crosses. This study suggested
that there was great genetic influence on tumor growth caused by RSV.
Several studies have shown that the B complex in chickens is comparable to the MHC molecules
in other species, including humans. However, the mammalian MHC has greater genetic variation as a
result of more balanced selection (Aquilar et al., 2003). The chicken B complex contains 19 genes
compacted into a 92-kb region, making it much smaller than the Human Leukocyte Antigen (HLA), the
human MHC. The small size and simplicity of the chicken MHC makes it useful in studying pathogenspecific disease resistance (Kaufman, 1999). Kaufman et al. (1999) has sequenced the chicken MHC
complex and has revealed that there are minimal counterpart genes in the HLA, signifying conservation of
the chicken MHC for over 200 million years, during which time the divergence of mammals and birds
occurred.
The MHC complex consists of genes which code for cell surface receptors responsible for
adaptive immune response. Class I MHC molecules are present on all nucleated cells and class II MHC
molecules are present only on antigen presenting cells (APC’s). The most common APC’s include
dendritic cells, macrophages and B lymphocytes. These cells express the MHC II complex which displays
a peptide that binds to the T-cell Receptor (TCR) of CD4+ T lymphocytes, also known as Helper T-cells.
The TCR recognizes the peptides via amino acid sequence; The TCR’s are specific for one peptide
displayed on one antigen. Once a TCR recognizes a peptide, the T-cell is activated leading to clonal
expansion and differentiation, activation of macrophages, and activation of B-cells for antibody
production. The polymorphism of the MHC genes creates the specificity and diversity of the antigen
recognition process performed by T-cells which stimulates the immune response (Abbas, 2012). It is
important to have a high number of specificities in one individual’s MHC genes to ensure healthy
immunity against pathogens. Class I MHC molecules and an endogenous antigen peptide are recognized
by the TCR of CD8+ T lymphocytes to become activated cytotoxic T lymphocytes (CTLs). CTLs are
specialized to kill cells infected with intracellular microbes, including viruses, and tumors expressing tumor
antigens (Abbas, 2012). When infected with RSV, the genetic variation, or lack thereof, in class I
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molecules influence the cellular response. If there is not a strong binding between the TCR of the CD8+
T-cell and the antigen being presented by the class I MHC molecule, infected cells can proliferate and
form sarcomas. The genetic variation in the MHC region is crucial to infection and disease resistance.
For an immune response to occur, antigen-specific receptors must recognize antigens and illicit a
response between T-cells and macrophages, dendritic cell, or B-cells with one product being antibodies.
As previously explained, MHC molecules play an important role in immune response to pathogens, and
are restricted to certain identities making the cells specific for one antigen such as a viral subgroup of
Rous Sarcoma Virus (Taylor, 2004). There are two classes of chicken MHC molecules and they show to
be analogous to those of mammals: the B-F and B-L classes of MHC molecules, making the chicken a
great model for immunological studies. However, the chicken has a third unique class of MHC molecule
named the B-G class. Additional genes in the chicken MHC region involved in lymphocyte and TAP2
(transporter associated with antigen procession) activation are also homologous to most mammalian
genes. In the chicken, the MHC antigens are also required for cellular communication in immune
responses. The peptides that are presented by the MHC molecules are different for each individual with
genetically different MHC sequences. This feature allows a broader spectrum of immune responses
against diseases as well as maintains the individual from self-destruction (Lamont, 1998).
Today, many agree that not one single mechanism is accountable for these large differences
among individuals. Selection and recombination together fulfill the role of MHC generation (Hess et al.
2002). The selection involved in the creation of the MHC polymorphisms of these genes is balanced by
two different types of selection: overdominant selection and frequency-dependent selection (Parham et al.
1996). Overdominant selection is the process by which individuals that are heterozygous at certain loci
are more likely to survive and have higher fitness. This is true for MHC genes because if there are two
different haplotypes expressed for a pathogen, that individual can elicit a more effective immune
response against a larger number of pathogens than an individual homozygous at that locus. Frequencydependent selection results when a certain allele in a population is strongly selected due to an epidemic,
in turn causing a more effective immune response against a particular pathogen. After time, this allele
may increase in frequency until it dominates the locus, known as fixation (Parham et al. 1996). In this
study, it was hypothesized that the AP and AR chicken lines would show several fixations in the genome
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due to a similar scenario. In the areas of fixation, the two lines would have differing alleles, as they were
selected divergently based on phenotype.

MHC genes associated with resistance to RSV induced tumor developments
There are two sub regions of the chicken MHC complex, the B and Y complexes, assort
independently, each contain MHC class I and MHC class II genes, separated by the nucleolar organizer
region (NOR) (Miller et al., 1996). Hosomichi et al. (2008) found that the B-complex of chickens, just as
the human HLA, derives its diversity using several different mutational events. Hosomichi et al. (2008)
sequenced a 14-gene region in the chicken MHC, which was a total of 59kb ranging from BG1 to BF2 on
the genome. The results suggested that some of the haplotypes were created from whole and partial
allelic gene conversion as well as homologous reciprocal recombination on top of the nucleotide
mutations. These haplotypes associate with some diseases that compromise the immune system;
however it is still unknown as to specifically which genes are associated to which disease responses
(Hosomichi et al., 2008).
There has been little research investigating the role of the Y complex in RSV resistance.
However, it has been determined that different Y genotypes influence tumor growth pattern, fate of tumor,
2

5

1.1

1.2

and mortality rates in chickens having a B B background and the three different Y alleles: Y , Y , and
6

Y (LePage et al., 2000). Another study performed by Pinard-Van der Laan et al. (2004) also indicated
that the Y complex had a small role in RSV resistance in two chicken lines selected for tumor progression
or regression (not the AR and AP lines used for this study). An overall tumor profile index (TPI) heritability
of 0.46±0.03 was observed for both regressor and progressor lines having the same Y genotype. The
study found a significant influence of Y genotype only in the progressor line. However, it was later
discovered that the progressor line from Pinar-Van der Laan’s study had the same sensitivity in the Ygenotype as the regressor line. Praharaj et. al (2004) concluded that the mechanism of the response was
different between the two lines. The progressor line exhibited an anti-tumoral response while the
regressor line exhibited more of an antiviral response. This led scientists to believe that non-MHC genes
are associated with tumor development caused by RSV. This study aims to identify any genes, MHC or
non-MHC that can be correlated to RSV-induced tumor progression and regression.

10

Non-MHC genes associated with resistance to RSV induced tumor development
Collins et al. (1985) discovered the involvement of non-MHC genes in the immune response of
RSV. The study monitored the tumor incidence and metastasis in chickens with several different
haplotypes. Some chickens with the same haplotypes had completely different rates of metastasis, for
5

5

example: 52 B /B individuals had an average metastasis rate of 60% while another group of 120
individuals with the same genotype had a rate of 31%. This indicated that a non-MHC genetic effect was
taking place on the metastasis of those chickens (Collins et al., 1985).
The specific loci involved in the association of RSV with the non-MHC genes are still being
studied. Gilmour et al. (1983) examined the effects of two non-MHC alloantigens, Ly-4 and Th-1, on
2

2

a

a

a

a

chicken lines (63 x 72) F5 birds (B B ). The Ly-4 Ly-4 /Th-1 Th-1 genotype showed significantly lower
a

b

tumor incidence. High tumor incidence resulted in the presence of Ly-4 and Bu-1 alleles and also the Lya

a

4 and Bu-1 alleles in line (63 x 100) F4 progeny. This line had Ly-4 and Bu-1 segregated on a shared
2

2

B B background (Gilmour et al. 1986). This thesis will further discuss the possible non-MHC genes
involved in RSV induced metastasis in chickens.

MARKERS ASSOCIATED WITH TUMORS AND CANCER

Technological advances such as PCR, next generation sequencing, SNP chips, and gene
expression assays have decreased the cost and efforts in biomarker discovery. These techniques have
helped identify biomarkers that aid in cancer prognoses, diagnoses, and treatments. For many cancers,
tumors develop due to genetic mutations affecting protein synthesis. The human papilloma virus (HPV)
causes cancer and/or growths, similar to RSV. Based on data from 2006-2010, it is estimated that 33,200
HPV-related cancers occur each year in the United States. Recent studies show that HPV is responsible
for more than 90% of cervical cancer and is associated with roughly 70% of cancers of the oropharynx
(Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 2014). Two
genes, C4.8 and C21.7, were found to be present in over 58% of all cancers, being potential biomarkers
in early cancer prognosis (Nees et al., 1998). In 2012, Next Generation Sequencing (NGS) enabled
discovery of 7241 somatic point mutations, mutations in 40 cancer genes and 73 combinations of mutated
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cancer genes (Stephens et al., 2012). Studying the genetic variations contributing to RSV-induced tumor
growth can add valuable knowledge toward cancer research. Biomarkers can help scientists pinpoint
areas of the human genome responsible for the onset of cancer, thus getting close to finding a cure for
cancer.

NEXT GENERATION SEQUENCING AND SNP DISCOVERY

Next generation sequencing (NGS) has made whole-genome sequencing attainable and practical
for researchers. Advantages of NGS include: higher resolution, more accurate readings, and large
volumes of data in a short amount of time. One method of NGS, whole genome sequencing, is especially
ideal for identifying causative variants providing scalability and flexibility (Illumina, 2015).
Next generation sequencing is commonly applied to livestock populations to increase economic
value. Today geneticists select agricultural animals to improve performance and lower disease risk.
Single Nucleotide Polymorphisms (SNPs) have become particular interesting in studying genotypicphenotypic relationships. One SNP or a combination of SNPs can be indicative for a phenotype, such as
growth rate, egg production, or disease susceptibility. If a SNP is found to be fixed and is associated with
a particular phenotype, geneticists can use that SNP as a biomarker to improve selective breeding in
chickens. Molecular genetics and traditional genetics are both being used together in selection
techniques in breeding programs and will continue complementing each other while technological
advances continue (Emmerson, 1997).
In 2004, the first draft of the Gallus gallus genome was published (v2.1). The most recent version
(v. 4.0) was released in 2011 (International Chicken Genome Sequencing Consortium, 2004). The
genome assembly is for one female Red Jungle Fowl (RFJ) from the UCD001 line and is considered the
closest living ancestor of the domestic chicken. The reference genome is approximately 1,000 Mb in
length and contains approximately 20,000 genes across 38 autosomes and one pair of sex
chromosomes. The most recent assembly of Homo sapiens is approximately 3,200Mb in length and
contains 20,000-25,000 protein-coding genes (International Chicken Genome Sequencing Consortium,
2004), making the chicken genome one third its size. The publication of the whole genome of the chicken
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has greatly influenced molecular genetics, providing major advances not only in the medical field, but
agricultural research as well.

SUMMARY
In this thesis, next generation sequencing and annotation was performed for AR and AP lines
using the RJF genome as a reference (International Chicken Genome Sequencing Consortium, 2004).
Using this technique, SNPs were identified as candidate biomarkers associated with specific phenotypes
of the AR and AP lines. The selection of SNP’s was based on gene function and diverging SNP
frequencies between the two lines. The SNP’s were tested in two different unrelated populations, GJF
and WL to determine whether or not the chosen SNPs were indeed potential biomarkers for predicting the
fate of sarcomas in chickens. Results indicated the chosen SNPs were not indicative of the regression or
progression of RSV-induced tumors. Although, SNPs were not validated within each line, the GJF and
WL exhibited genetic differences in SNP frequencies and grand mean tumor scores in relation to each
other.
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CHAPTER 2: WHOLE GENOME SEQUENCING AND DATA ANALYSIS FOR
AP AND AR LINES
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INTRODUCTION
Whole genome sequencing is a useful method to study evolutionary mechanisms and genetic
variation (Amaral et al, 2011). With technological advances in genetics and genomics, whole genomes
can be sequenced at a relatively low cost and in a short amount of time. Whole genomes for several
organisms, including the ancestral wild chicken, Red jungle fowl, have been successfully sequenced and
published (International Chicken Genome Consortium). Massively parallel next-generation sequencing
technologies for large-scale re-sequencing of cohorts of individuals with a known reference have become
popular in performing genetic variation studies. Massively parallel next generation sequencing technology
was used to resequence the chicken genome in an effort to identify loci associated with chicken
domestication (Rubin etal. 2010). Rubin et al. generated 44.5-fold coverage of the chicken genome using
pooled genomic DNA representing 8 different chicken populations, as well as the ancestral line, the Red
Jungle Fowl. Results from this study identified over 7,000,000 SNPs, almost 1,300 deletions and some
selective sweeps. A selective sweep occurred at the locus for thyroid stimulating hormone receptor
(TSHR), playing a crucial role in metabolic regulation and photoperiod, was identified as a genetic marker
indicative of domestication.
Genome wide association studies (GWAS) have been used to find differences in certain regions
of the chicken genome under selection. Lan et al. (2015) used the GWAS method to isolate specific loci
between the broiler and layer chickens to support the production of indigenous chicken breeds. Results
suggested that alternative indigenous breeds could be used in place of the broiler and layer chicken. Next
generation sequencing and GWAS methods have also been utilized to investigate genetic resistance and
susceptibility to certain diseases. Two domestic chicken lines, divergently selected for susceptibility to
Marek’s disease (MD), were used to identify the genetic and molecular basis for resistance to MD. Yan et
al., reported that birds found to be susceptible to MD had fixed copy number variation regions (CNVRs)
containing several genes involved in the MAPK signaling pathway and 62 genes strongly associated for
the susceptibility to MD. The divergently selected Arkansas Progressor (AP) and Arkansas Regressor
(AR) chicken lines can be an animal model for disease resistance and investigation on genome wide
scale variation, for AP and AR lines may provide genetic information that can be used for diagnoses,
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treatment, and genome-wide selection strategy. GWAS can identify genome variation and provide insight
to the genetic correlates of phenotypic changes.
The objective of this study was to identify potential genetic biomarkers for tumor regression and
tumor progressions using the two divergently selected AP and AR chicken lines.This was the first whole
genome sequencing conducted to analyze SNP variations in these two chicken lines. Pooled genomic
DNA representing both lines was sequenced using Illumina technology and a reference based assembly
using the sequences of Red Jungle Fowl, common ancestor of all domestic chicken breeds. Not only can
this study provide insight into genetic variation between the AP and AR lines, but also provide useful data
toward domestication and biomedical research.
MATERIALS AND METHODS
Genetic Lines
Two divergently selected chicken lines, AP and AR, which have been maintained by N.B.
Anthony at the Arkansas Agricultural Experimental Station (AES), were use in this study. AP line chickens
are susceptible to tumor progression after infection of RSV, while AR line chickens are resistant to tumor
development after RSV infection. To produce the AR and AP birds for this study, matings were achieved
via artificial insemination of 148 females with pooled semen from 74 males. Details on the method of
selection used to create these two lines are described in Chapter 1.
Sampling and DNA preparation
To obtain DNA samples for whole-genome sequencing, 0.5 ml of blood was collected via wing
web puncture from 12 birds each from the AP and the AR lines. Genomic DNA was then extracted using
a QiaAmp DNA mini kit (Qiagen, Valencia, CA) following manufacturer’s instructions. Extracted DNA
quantity was determined by NanoDrop spectrophotometry (Thermo Scientific, Waltham, MA) and quality
by agarose gel electrophoresis. Equal nanograms of DNA from 10 samples showing the highest quality
were pooled to represent each respective line. Quality of DNA was based on DNA concentration.
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Genome Sequencing and Assembly
Library construction and whole-genome sequencing of the pooled DNA were performed by the
National Center for Genome Resources (NCGR: Santa Fe, NM) using Illumina HiSeq 2x100 bp paired
end read technology. The raw sequence read data were assembled and aligned with the Red Jungle
Fowl (gal gal 4; GenBank accession number: GCA_000002315.2 ), using SeqMan NGen program of the
Lasergene software package ( version 12.0 DNAstar, Madison, WI). Assembly parameters are listed in
Table 1.
Data Analysis I (SNP filtering)
After assembly, SeqMan Pro (LaserGene software program) was used to identify candidate SNPs
for the entire genome. The SeqManPro SNP report was exported to Microsoft Excel and further analyzed.
Duplicate SNPs homozygous in both AP and AR, were filtered out leaving only unique SNPs to observe
any fixations between the two lines. The SNP percentages, or SNP frequencies, are defined as the ratio
of reads containing the SNP to total read number. Any SNPs with less than 75% SNP frequency and a
read depth of less than 10 were filtered out of the dataset to obtain more reliable SNPs. The SNP
frequency of the AR line was subtracted from those of the AP line. If frequency in AP- frequency in AR
was equal to – 1 (1.00), the SNP was to be fixed at 100% frequency for the AR line at that SNP location.
Likewise, when the difference of SNP frequency between AP and AR is ±1.00, the SNP was considered
to be fixed at 100% in the AP line. These were considered potential areas of the genome to further
analyze to find candidate genes containing biomarkers.
Using the remaining SNP data for all chromosomes, SNP frequencies were averaged over a 40SNP window to show determine if any clusters of SNPs were present at chromosomal locations. This data
was then graphed to identify clusters of fixed SNPs at their chromosomal location (data not shown). The
outlying peaks which are much larger than the normal distribution of the graph are the areas of clustered
SNPs. These areas were targeted for initial SNP analysis and further analyzed to find genes with
functions associated with tumor growth, cancer, and the cell cycle.
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Data Analysis II (SNP filtering)
For initial genomic analysis of SNP data, SNPs showing a depth of 10 or higher were considered
for validation (Data Analysis I). The validation results revealed that these SNPs were false positives
caused by filtering out important SNPs. Thus, the depth limit was decreased to three rather than ten.
Duplicated SNPs with a read depth of two or less were filtered out to ensure fixation of that SNP in only
one of the two lines. The unique SNPs with a SNP frequency less than 75% were then filtered out of the
dataset High frequency, unique SNPs found in coding DNA sequence (CDS) and non-coding regions
were grouped into various categories including: mutations of frameshift, no start, no stop, nonsynonymous, and non-sense, which may generate mutations in the amino acid sequences which may
have an impact on the phenotypic changes. SNPs that appeared to be fixed were confirmed further at the
SNP locations using the alignment view of SeqMan Pro program. The actual reads were aligned on the
references where the SNP frequency in each line could be verified. SNPs lying within genes with high
frequencies and also functional activities in the cell cycle, cancer, the immune system or tumor growth
were chosen to further investigate in a larger population.
RESULTS AND DISCUSSION
Genome Sequencing and Assembly
The average coverage for all chromosomes was 9.9x. The total number of reads for AP and AR
lines was 69,221,284 and 55,368,344 respectively (Table 2). SeqMan Pro identified more than 9,000,000
SNPs in both AP (4,948,899) and AR (4,407,630) lines, most SNPs being in chromosomes 1-3. Figure 2
shows the distribution of SNPs per chromosome.
Data Analysis I (SNP filtering)
During the data filtering process in Microsoft Excel, over 388,000 SNPs were found with a read
depth of 10 or more in the AP and AR lines (Table 2), but only 12,000 were unique between the AR and
AP lines. Further filtering revealed that 7,162 unique SNPs had a 75% or higher SNP frequency.
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Although SNPs located within non-protein coding regions can be significant biomarkers, not all
SNPs could be considered in this study due to the time required for a large scale SNP analysis. If a
candidate SNP outside the protein coding region is found to be highly associated with the phenotype of
interest, it is plausible that the association is due to linkage disequilibrium. However, the linkage between
two markers would decrease over time due to meiotic recombination events eventually breaking the
linkage of the marker and phenotype (Brookes, 1999). Although this is true, it is still possible for SNPs in
non-coding regions of genes to be associated with the phenotype of interest.
Once filtering was completed, ten SNPs were chosen based on SNP frequency and the gene
function in which the SNP resided. The ten candidate genes chosen to test included RALA, STK17A,
CDKN2A, CDKN2B, POU6F2, NCK2, PSMA2, SMOC2, ADRBK2, and CDK13.The gene descriptions are
listed in Table 4. As mentioned before, these candidate SNPs were shown to be false positives after
testing these SNPs in a larger number in AP and AR chickens. Thus the second data analysis was
performed as follows.
Data Analysis II (SNP filtering)
After the second data analysis, candidate SNPs were selected, and the nine new SNPs were
found to be reliable candidate SNPs for further testing. All had a SNP frequency of 100% in the initial
genomic analysis from the 10 pooled samples. After the second filtering process was completed, the
unique SNPs were categorized by mutation: Frameshift (134), No Start (25), No Stop (7), Nonsynonymous (6884), and Nonsense (112) (Table 6). The second data analysis revealed 9 candidate
genes containing a SNP of interest. These genes include: IL16, IL2RA, CDK13, CASP9, FGF14, MAP1A,
POU6F2, NCK2, and ATAD5. The descriptions of these genes can be found in Table 5.
Genome Sequencing and SNP Analysis
Whole genome sequencing has been proven to be a reliable method in identifying loci under
intense genetic selection in chickens as well as other species. This method has been performed to study
the domestication of the chicken, the impact of genetics on disease resistance, and marker assisted
selection in agricultural chicken populations (Rubin et al., 2010; Lan et al., 2015). Gheyas et al. (2015)
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detected 15,000,000 SNPs using next generation sequencing in diverse chicken populations in order to
predict variants with potential functional implications from coding and non-coding regions. The study
reported 183K SNPs, which resulted in amino acid alterations and identified regions of local fixation within
commercial broiler and layer lines. Ninety-four variants were detected from various putative selective
sweeps to be fixed exclusively in broilers, most of which resided on chromosome 1 and represented
genes: PARPBP, PMCH, NUP37, CCDC53, GNPTAB, SYCP3 and CHPT1. The nine SNPs detected in
AP and AR lines in this study have the potential to indicate RSV- induced tumor susceptibility and may
provide insight into the etiology of cancer causing viruses such as the Human Papilloma Virus (HPV),
infecting about 14 million people each year resulting in 11,000 women getting cervical cancer (Centers for
Disease Control and Prevention, U.S. Department of Health and Human Services, 2015). The whole
genome sequencing results from this study can also provide potential opportunities to further study the
genetic mechanisms involved in tumor development in humans. The effects of intense human-driven
selection based on phenotype can also be studied to aid in animal breeding programs.
Today, next-generation sequencing plays a major role in clinical applications of genomic
disorders, especially cancer. Various types of genetic mutations, point mutations, genomic
rearrangements, gene fusions, or chromosomal alterations can contribute to disease initiation and/or
progression (Kim et al., 2013). The AP and AR chicken lines serve as an excellent model to study the
effects of genetic mutations which may contribute to tumor growth. The genetic mutations found to be
responsible for disease can be used as biomarkers for prognosis or treatment therapies in humans.
Roychowdhurty et al. (2011) developed a cancer patient protocol that includes genome sequencing of the
cancer genome to evaluate the mutation profiles of the patient to aid in clinical decisions. In their pilot
study, sequencing tumor board (STB) found that a patient with metastatic colorectal cancer had an NRAS
mutation and CDK8 amplification. This finding concluded that BRAF/MEK inhibitors and PI3K and/or CDK
inhibitors could be beneficial for that patient. Some of the same markers found in the human genome
have a similar counterpart in the chicken genome, giving reason to use the chicken as a model for
biomedical research.
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CONCLUSION
The chicken genome has 20,000- 23,000 genes and 1 billion base pairs and the human genome
has 20,000- 25,000 genes and 3.2 billion base pairs. The chicken and human genomes contain 60%
corresponding genes, which are 75% identical on average, making the chicken a useful model for
genome evolution and human biology (National Institutes of Health, 2004). Genome analysis showed that
the puffer fish shares 72% of the corresponding chicken and human genes, suggesting similar
percentage of gene correspondence in all vertebrates. The SNP data for AP and AR chicken resulting
from this thesis can be further analyzed for cellular interaction pathways, contributing knowledge of the
genetic mechanisms involved immune response to disease. All nine of the selected SNPs were located
within a gene with functionality related to various signaling pathways in cells and have a corresponding
gene in the human genome. The chicken is a great model for human cancer research, as well as other
diseases. Other chicken lines at the University of Arkansas have been created not only to improve
economic value but also to serve as models for various diseases, such as hypertension and vitiligo in
humans (Anthony, N.B.; Erf, G.).
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Table 1: Assembly parameters
Assembly parameters for the alignment of AP and AR genomes to the reference genome.
SeqMan NGen program of the Lasergene software package (DNAstar, Madison, WI) was used
for the assembly with listed parameters
Table 2: Combined summary for NGS of AP and AR lines
Combined total numbers of contig length, contig length without gaps, total sequence length,
number of sequences, average coverage, and cumulative contig length (without gaps) for each
chromosome for AP and AR genomes.
Table 3: Summary for NGS results for AP and AR lines
Total number of reads, aligned reads, and unaligned reads for AP and AR chicken lines
Table 4: Data Analysis I- gene descriptions (RefSeq, Jul 2008)
Gene names, descriptions, and SNP locations for initial ten SNPs chosen as candidate
biomarkers resulting from the first data analysis. SNPs listed were validated as false positives
except NCK2 and POU6F2
Table 5: Data Analysis II- gene descriptions (RefSeq, Jul 2008)
Gene names, descriptions, and SNP locations for nine SNPs chosen as final candidate
biomarkers resulting from the second data analysis
Table 6: Summary of categorized mutations after Data Analysis II
Number of categorized mutations after second data analysis for AP and AR lines
Table 7: Candidate SNPs chosen for potential genetic biomarkers
Gene names, reference position, reference base, mutation type, called base, SNP frequency,
genotype, and feature of nine final candidate SNPs chosen for potential genetic biomarkers
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Figure 1: Possible number of total SNPs per chromosome for AP and AR lines
Possible number of total SNPs per chromosome for AP and AR lines combined, with more than 4
million SNPs occurring in chromosomes 1-3.
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Table 1: Assembly parameters
Layout Options
Repeat read placement
Maximum repeat count:
Maximum total read:
Assembly output format
Alignment Options

place once
100
10000000
BAM assembly package

Minimum aligned length
Maximum gap size
Minimum match percentage
Mismatch penalty
Gap penalty
Auto trim reads
SNP Options
Calculate SNPs
SNP calculation method
Minimum SNP percentage
SNP confidence threshold
Minimum SNP count
Minimum base quality score
Check strands

25
6
93
20
30
on
on
Diploid Bayesian
5
10
2
5
off
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Table 2: Combined summary of NGS for AP and AR lines
Chromosome
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mtDNA
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
32
W
Z
O
P
__________________
totals
average

Contig
Length
16795
195486522
148964650
110564444
90317033
59644960
34991399
36284861
28798905
23468928
19933620
19423623
19919731
17780811
15179679
12670337
535984
10468340
11232318
9994848
14318198
6811114
4085298
5729945
6330974
2193591
5336208
5215342
4747584
1070
1249589
82420785
966208
801117
___________
1005884811
29584847.38

Contig
Length(woGaps)
16775
195276750
148809762
110447801
90216835
59580361
34951654
36245040
28767244
23441680
19911089
19401079
19897011
17760035
15161805
12656803
535270
10454150
11219875
9983394
14302601
6802778
4081097
5723239
6323281
2191139
5329985
5209285
4742627
1028
1248174
82363669
965146
799899
__________________
1004818361
29553481.21

Total
Seq. Length
250100
2009697400
1509047700
1131729100
925996300
613492100
364903100
379173800
299465000
246802800
206727600
203894200
208543100
184949900
159867500
131905300
4881900
123699000
111650900
105255300
146270200
69697900
43324600
57035500
64356500
16783800
49848200
49829200
41466400
451000
10306300
473442700
8149000
10439700
______________
9963333100
293039208.8

Number
Seq.
2501
20096974
15090477
11317291
9259963
6134921
3649031
3791738
2994650
2468028
2067276
2038942
2085431
1849499
1598675
1319053
48819
1236990
1116509
1052553
1462702
696979
433246
570355
643565
167838
498482
498292
414664
4510
103063
4734427
81490
104397
________
99633331
2930392.088

Avg.
Coverage
14.89
10.28
10.13
10.24
10.25
10.29
10.43
10.45
10.4
10.52
10.37
10.5
10.47
10.4
10.53
10.41
9.11
11.82
9.94
10.53
10.22
10.23
10.61
9.95
10.17
7.65
9.34
9.55
8.73
421.5
8.25
5.74
8.43
13.03
___________
22.21647059

Cumulative
Contig Length(woGaps)
16775
195293525
344103287
454551088
544767923
604348284
639299938
675544978
704312222
727753902
747664991
767066070
786963081
804723116
819884921
832541724
833076994
843531144
854751019
864734413
879037014
885839792
889920889
895644128
901967409
904158548
909488533
914697818
919440445
919441473
920689647
1003053316
1004018462
1004818361
________________

Table 3: Summary of NGS Results for AP and AR lines

LINE

Total # of reads

Total # of reads aligned

Total # of reads not aligned

AP

69,221,284

55,224,050

10,903,306

AR

55,368,344

44,328,649

8,551,173

Table 4: Data Analysis I- gene descriptions (RefSeq, Jul 2008)
Gene

SNP location (Chr:Mpb)

Gene descriptions

RALA

2:504442109

v-ral simian leukemia viral oncogene homolog A (ras related)

STK17A

2:5211119

Serine/threonine kinase 17a

CDKN2A

Z:78453153

Cyclin-dependent kinase inhibitor 2A

CDKN2B

Z:78463164

Cyclin-dependent kinase inhibitor 2B

POU6F2

2:50117844

POU class 6 homeobox 2

NCK2

1:134690198

NCK adapter protein 2

PSMA2

2:51749203

Proteasome (prosome, macropain) subunit, alpha type 2

SMOC2

3:40985084

SPARC related modular calcium binding 2

ADRBK2

15:7043072

Adrenergic, beta, receptor kinase 2

CDK13

2:50507153

Cyclin-dependent kinase 13
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Table 5: Data Analysis II- gene descriptions (RefSeq, Jul 2008)
Gene

SNP location

Gene descriptions

CDK13

2:50469650

Cyclin-dependent kinase 13

NCK2

1:134690198

NCK adapter protein 2

POU6F2

2:50117844

POU class 6 homeobox 2

IL2RA

1:3380404

Interleukin 2 receptor, alpha

ATAD5

18:6611691

ATPase family, AAA domain containing 5

CASP9

21:4919322

Caspase 9, apoptosis-related cysteine peptidase

FGF14

1:142233297

Fibroblast growth factor 14

IL16

10:11603087

Interleukin 16

MAP1A

10:19701184

Microtubule-associated protein 1A

Table 6: Summary of categorized mutations after Data Analysis II
Type of SNP

# SNPs in AR

# SNPs in AP

Non-synonymous

5586

6771

Non-sense

45

66

No Start

19

20

No Stop

7

7

Frameshift

88

148
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Table 7: Candidate SNPs chosen for potential genetic biomarkers

GENE

LINE

CHR

REF
POSITION

REF
BASE

MUTATION

CALLED BASE

SNP % of
called base

Genotype

Feature

IL16

AP

10

11603087

T

Non-synonymous

C

100%

Homo. Var

CDS

FGF14

AP

1

142233298

T

Non-coding region

C

100%

Homo. Var

gene

IL2RA

AP

1

3380404

C

Nonsense

T

100%

Homo. Var

CDS

MAP1A

AP

10

19701184

G

Non-synonymous

A

100%

Homo. Var

CDS

CDK13

AR

2

50496950

G

Non-synonymous

A

100%

Homo. Var

CDS

ATAD5

AR

18

6611691

C

stop codon

T

100%

Homo. Var

CDS

CASP9

AR

21

4919322

G

Nonsense

A

100%

Homo. Var

CDS

POU6F2

AR

2

50117844

T

Non-coding region

G

100%

Homo. Var

gene

NCK2

AR

1

134690198

T

Non-coding region

T

100%

Homo. Var

gene
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Figure 1: Possible number of total SNP’s per chromosome for AP and AR lines

2000000
1800000
1600000
1400000
1200000
34

1000000

# SNPs

800000
600000
400000
200000
0
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 32 W Z O P

CHAPTER 3: VALIDATION OF CANDIDATE SNPs ASSOCIATED WITH RSV-INDUCED
TUMOR DEVELOPMENT
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INTRODUCTION
Identifying and understanding genetic mechanisms by which evolutionary changes occur can
provide knowledge to better understand the association between genotypic and phenotypic
characteristics of organisms. Domestic animals, such as the chicken, serve as excellent models for
genetic studies involving phenotypic evolution caused from disease. Human-driven selection has led to
genetic adaptations responsible for significant phenotypic changes. Current advancements in molecular
genetics have driven the identification of genetic markers and provided opportunities to improve
conventional selection when the desired phenotype is not measurable and/or has low heritability
(Dekkers, 2003).
The poultry industry has struggled to link targeted phenotypes with genotypes, but continues to
research as more advanced molecular methods are discovered. GWAS (Genome Wide Association
Studies), differential gene expression, and resequencing are among the commonly used methods for
genetic variation studies. Luo et al. (2014) performed a GWAS using 43,211 SNP markers to identify the
loci involved in the immune response to the infection of infectious bronchitis (IBV) in the chicken. The
study detected 20 significant SNPs related to the anti-body response to IBV. Differential expression
between Marek’s disease (MD) infected spleens and non-infected spleens results showed downregulation of gga-miR-199-3p at 14 and 28 dpi and expression of miR-140-3p decreased at 14 dpi,
suggesting an important role in the early stages of tumorigenesis (Lian et al., 2015). Huang et al. (2015)
used DNA sequencing and PCR-RFLP as a means to link genotypes of BMP15 and GDF9 to egg
production. Two SNPs, one in each gene, were found to be associated with total egg production at 300 d.
of age and age of first lay. This study concluded that Marker Associated Selection (MAS) of BMP15
genotypes could significantly improve total egg production at 300 d. of age in Shaobo hens. Whole
genome sequencing can also be utilized to identify genetic mutations. This method has been used to
pinpoint functional variants from association studies, improve evolutionary biology research, hence
creating the ability to predict disease susceptibility and drug response.
Whole genome sequencing can help researchers understand the functionality of the genome in
relation to the development of genetic adaptations. Before the development of whole genome
sequencing, Restricted Fragment Length Polymorphism (RFLP) analysis and microsatellite analysis were
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common techniques used to find genetic variation. These methods investigate small regions of the
genome with minimal knowledge of the gene sequences. Whole genome sequencing has become less
time-consuming and costly, providing benefits to genetic research in terms of efficiency and quality. In this
study, the Arkansas Progressor (AP) and Arkansas Regressor (AR) chicken lines were used as a model
to identify genetic mutations responsible for Rous sarcoma virus (RSV) induced tumor development.
Whole genome sequencing was performed and genome-wide SNPs were identified and analyzed for AP
and AR lines. Nine SNPs were identified as being potential biomarkers for tumor regression or
progression in chickens post RSV inoculation. The nine candidate SNPs were further tested in larger
populations to confirm their presence in AP and AR lines. SNPs showing high frequencies and
divergence in larger populations were chosen as genetic biomarkers for marker-assisted selection for
RSV tumor-induced resistance.
MATERIALS AND METHODS
DNA sampling and preparation
At two weeks of age, blood was sampled via wing web puncture from more than 50 birds for each
the AP and AR chicken lines. Approximately 2-3 drops (100-200µL) of blood was collected and stored in
100µl sodium citrate (C6H8O7) to prevent clotting. Genomic DNA was extracted from the blood using the
Wizard SV 96 Genomic DNA Purification System (Promega; Madison, WI) following manufacturer’s
instructions with some modifications. In the PCR plate format, the top four rows (48 wells) contained AR
line samples and the bottom four rows (48 wells) contained AP line samples. Whole blood (10µL) was
carefully mixed with proteinase K (6.7µL/µL) and incubated at room temperature for 10 minutes. The lysis
buffer (300µL) and triton X-300 (33µL) was mixed and then added to RNase A (55µL) in one boat. This
mixture was then added to the blood/proteinase K mixture and blood clots were dissociated by repetitive
pipetting. After complete dissociation of blood clots, a vacuum manifold system was used to filter lysate
through the filters of the binding plate. Three consecutive cycles of ethanol washing was applied and
followed by elution with nuclease- free water (200µL). DNA concentration was quantified using a
Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA). For all samples, a
1ng/µL dilution was prepared in empty 96 well plates as an aliquot for PCR.
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Primer Design
A forward, reverse, and sequencing primer were designed with reference to the RJF genome
sequences (gal gal 4;GenBank accession number: GCA_000002315.2) at the SNP locations using online
program Primer 3 Plus (http://primer3plus.com/cgi-bin/dev/primer3plus.cgi) (Untergrasser et al., 2007).
Primers were designed to have 20-22 nucleotide bases and approximately 50% GC content. Sequencing
primers were designed to anneal to at least 50bp or more upstream of the SNP location. Forward and
reverse primers were designed to anneal to the flanking regions of the sequencing primer and the SNP
location. The lengths of PCR product ranged between 431-520bp. All working primers were synthesized
by Integrated DNA Technologies (Ames, IA). Working primers were prepared to a concentration of
20ng/µL. A total of 9 primer sets were designed, one for each candidate gene, and these can be viewed
in Table 1.
PCR
PCR was performed on a 96-well format for all 9 candidate genes for both the AR and AP lines.
These included IL16, FGF14, IL2RA, MAP1A, CDK13, ATAD5, CASP9, POU6F2, and NCK2. The top 4
rows of the 96-well plate contained AR samples and the bottom 4 rows contained AP samples. The 96
well format can be seen in Figure 1. Total reaction volume for PCR was 25µL: 5µL DNA (1ng/µL), 2.5µL
10x buffer, 1µL 2.5mM dNTP mix, 2µL F primer, 2µL R primer, and 0.5µL Taq Polymerase (NEB; Ipswich,
MA). PCR conditions were as follows: denaturation at 95ºC for 1 min, 40 cycles of amplification (95ºC for
30 sec, 60ºC for 1 min, 72ºC for 1 min), and a final extension at 72ºC for 10 mins. PCR assays were
performed using Applied Biosystems 2720 Thermal Cycler (Life Technologies, Carlsbad, CA). Validation
of PCR product was performed by 1% agarose gel electrophoresis.
Gel Electrophoresis
To test quality of PCR product, 5µL was mixed with 6x loading dye, prepared with bromophenol
blue and xylene cyanol dyes. The mixtures were loaded into wells of a 1% agarose gel using 1x TAE
buffer solution. The first well was loaded with 5µL Hi-Lo DNA molecular weight marker (Bionexus, Inc.,

38

Oakland, CA) to confirm PCR product size of each sample. Gel images were obtained using a Bio-Rad
Gel Doc XR imaging system (Bio-Rad Laboratories, Hercules, CA).
PCR product purification
After gel electrophoresis, PCR product was purified using the Wizard SV 96 PCR Clean-Up
System (Promega; Madison, WI) following manufacturer’s protocol. Prior to PCR purification, 8µl of four
different PCR products were pooled into one 96-well plate totaling 32µl in each well. Each well contained
four different samples derived from the same bird (Figure 2). Before pooling these samples, the crossspecificity of the sequencing primers to the other PCR product sequences was assessed using the
BLAST function (NCBI). Membrane-binding solution (32µL) was added to the pooled PCR products and
vacuum pressure was applied. Three washing steps with 95% ethanol were applied and the PCR
products were eluted with 100µL nuclease-free water. The DNA concentration was quantified using the
NanoDrop 1000.
Sanger Sequencing
After DNA concentration was quantified, further pooling was performed. From the 96 well plates,
3µL from each well of each row were pooled into one tube (i.e.rows A1-A12). This resulted in 8 different
pooled samples containing purified PCR products of 4 different genes. Because these pooled samples
contained PCR products for 4 different genes, four separate aliquots were made for each sequencing
primer. Each sequencing primer was added separately so as to only show results for the desired gene.
To prepare for sequencing, 20ng of DNA was mixed with 1.5µl of the sequencing primer and distilled
water to yield 13µl total for sequencing reaction submission. Sequencing was performed in the DNA Core
Lab at the Tyson Center of Excellence for Poultry Science, University of Arkansas (Fayetteville, AR).
Sequencing results were analyzed with Sequence scanner software v. 1 (Applied Biosystems of Thermo
Fisher Scientific, Waltham, MA). Peak heights at SNP locations were examined and the ratios of allele
frequencies at the SNP locations were recorded.
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RSV Inoculation and blood collection
The bird population being tested was also observed for phenotypic data collection. Approximately
100 birds from each line were hatched and maintained at the AES (Fayetteville, Arkansas). To produce
the AR and AP birds for this study, matings were achieved via artificial insemination of 148 females with
pooled semen from 74 males. All chicks were given a wing band with a unique identifying number and
then placed randomly in pens. Feed and water were provided ad libitum during the grow-out of the birds.
Phenotypic data (tumor scores) were recorded for each bird/wing band in order to see tumor growth for
individuals over a duration of time.
At six weeks of age, all birds were inoculated subcutaneously with 70pfu Bryan-titer strain Rous
Sarcoma Virus (0.1mL) in the opposite wing web from where the blood sample was taken. The RSV virus
sample used in this procedure was of the C RSV subgroup (specifically RAV-49), and came from Dr. Aly
Fadly, USDA-ARS, Avian Disease and Oncology Laboratory, East Lansing, MI. The birds’ tumors were
monitored three times a week and recorded for 8-10 weeks post inoculation to track regression or
progression of tumors. A sizing scale from 0-5 was created to record the different stages of tumor growth.
A bird was considered resistant if no tumor developed on the wing web after inoculation. If a tumor of any
size developed, and regressed to zero, it was considered completely regressed. If a tumor of any size
developed, and regressed to 1, it was considered more resistant to RSV than birds of higher scores. Any
bird that developed a tumor without any regression was considered completely progressed. If a bird
developed a tumor and it regressed to anything greater than 1, it was considered less resistant to RSV.
Sizing scale can be reviewed in Table 2.
Images of example tumor sizes are shown in Figures 3-9. Once a tumor reached a score of 5 for
one week, and showed no sign of regression, the bird was humanely euthanized. Also, if the skin
covering the tumor broke open, and the contents were visible outside the tumor, the bird was humanely
euthanized. All birds were humanely euthanized 10 weeks post inoculation (AVMA Guidelines).
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Phenotypic Data Collection
The tumor scores for each line were recorded every 3-4 days on average for 67 days. The same
48 birds of each line used for SNP testing were used for phenotypic analysis. The tumor scores were
averaged for each day and then graphed against the days post inoculation (dpi). These data can be seen
in Figures 14 and 15.
RESULTS AND DISCUSSION
Genotypic Results
To determine SNP frequencies in large samples sizes for AP and AR lines, pooled PCR products
from 12 chickens were subjected to sequencing and the peak heights examined at SNP locations was
used to measure genotypic ratios. This method can illustrate an estimation of SNP frequencies in large
pooled samples. The accuracy of allele frequencies of pooled PCR products was determined by the
comparison of 12 individually sequenced samples at the SNP locations. Comparing peak heights of
pooled samples to determine the SNP frequency has been confirmed recently (Lee et al., 2014).
Results from PCR and sequencing of the first set of candidate genes derived by data analysis I
revealed that candidate SNPs were false positives, and only SNPs present in genes NCK2 and POUF6
occurring in the AR line showed fixed segregations from the AP line (data not shown). Although candidate
SNPs showed higher frequencies in the counter line, the fixation may not be high enough to be
considered a candidate gene, since this SNP was seen in both lines. Therefore, data analysis II was
performed and the seven new candidate SNPs, in addition to the SNPs occurring in NCK2 and POUF6,
were then tested in the same population of birds, 48 chickens per line.
The second set of candidate SNPs was tested and results were more promising; the sequencing
results are listed in Table 3. The SNP, located in the IL-16 (interleukin-16) gene, resulted in 100%
complete divergence between the two lines. The AR line had the same base (T) as the reference genome
with a 100% frequency and the AP line had a different base (C) than the reference genome with a 100%
frequency. In chickens, IL-16 is an inflammatory cytokine and also a precursor of protein for pro-IL-16
(Min et al., 2004). Yellapa et al. (2012) reported that higher levels of IL-16 serum were associated with
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tumor growth resulting from tumor-associated neoangiogenesis (TAN) in laying hens. The serum level
frequency of IL-16 was significantly higher in tumor-bearing hens than hens without tumors. Results
concluded that serum levels of IL-16 may potentially be indicative of TAN. IL-16 is a cytokine that is
involved in the innate immune response. A cytokine can play a major role in the regulation of both innate
and adaptive immunity. More specifically, most interleukins are responsible for promoting the
development and differentiation of T, B lymphocytes or natural killer cells (NK). Because the AP line is
known for tumor progression, The SNP found in IL-16 could play a role in tumor development and
resistance to RSV.
A SNP in the CDK13 (cyclin-dependent kinase 13) gene had complete divergence between the
two lines as well, however only 36 out of the 48 samples per line had successful sequencing results.
Sequencing results showed that this SNP was 100% fixed in the AR line with the “A” base, while the AP
line was fixed at 93.3% with the “G” base. Ansari et al. (2015) discovered genes which produced proteins
linked to pancreatic cancer were unique to pancreatic cancer patients and CDK13 was included in the list.
CDK13 , also known as CDCL25 (cell division cycle 2- like 5), has also been found to have high
oncogenic activity linked to tumorigenesis and was also amplified by an average of 30% in human
patients with hepatocellular carcinoma or colorectal cancer (Kim et al., 2012). CDK13 has been identified
as an essential protein that influences the cell cycle by regulating the activation of cyclins. Tumor
development is thought to result from a genetic alteration of a protein, which then affects the proliferation
of a single cell. That cell continues to proliferate until there is a tumor clonal population. Additional
mutations such as the SNP found in CDK13 may affect the cell cycle and cause overactive cell
proliferation leading to tumor development such as the sarcomas induced by RSV. Overactive cell
proliferation is considered an abnormality in the cell cycle and can be controlled by genetic mutations
(Cooper, 2000).
IL2RA (interleukin-2 receptor, alpha) had a 100% SNP (T base) frequency in the AP line and an
85.5% SNP (C base) frequency for the AR line. This gene, aka CD25, is the alpha chain of the interleukin
receptor, which is found on activated T cells. In humans, this gene was shown to have lower expression

42

in HIV infected individuals, possibly contributing to immune deregulation (Mendez-Lugares et al., 2014). A
mutation in the IL2RA gene could help identify the mechanism of virus-induced diseases such as HIV.
CASP9 (caspase-9) also had promising results having a 100% SNP (G) frequency for the AP line,
with the same base as the reference. The AR line did not match the reference and had an 83% SNP for
base A and a 17% SNP frequency for base T. CASP9 was discovered to play a role in the direct
regulation of apoptosis, and in turn tumor development. CASP9 is an oncogenic gene which is activated
by p53, a tumor suppressor gene, to promote apoptosis (Sonegas et al., 1999). CASP9 is yet another
candidate gene that could be contributing to the tumor development in the AR and AP lines due to its role
in tumor development in humans.
Additionally, ATAD5 (ATPase family, AAA domain containing 5), showed a 100% SNP (C base)
frequency in the AP line matching the reference base while AR had an 83.3% SNP (T base) and 17%
SNP (A base) frequencies. Bell et al. (2011) discovered that this gene may be important in suppressing
genomic instability in mammals in vivo. Using mice as their model, they found that 90% of ATAD5
haploinsufficient mice developed tumors. This may indicate that a mutation in ATAD5 affects tumor
development. The SNP found in ATAD5 for the AR line is different from the reference, suggesting that the
AR line may have experienced a mutation in favor of tumor regression.
SNP frequency in FGF14 (fibroblast growth factor 14) in the AP line was 100% (C base) while
the AR line showed 62.5% (T base) SNP frequency and matched the reference base. Although this SNP
is not completely divergent between the two lines, the 100% in the AP line may be significant. This SNP
is also located in the intronic region; however, it is possible for a mutation in an intronic region to affect
protein synthesis, especially if the mutation is close to the splicing site (Harland et al., 2001). The FGF
protein family (fibroblast growth factors) are responsible for binding to the FGF receptors to create a
dimerization to activate tyrosine phosphorylation in the SHP2/RAS/ERK signaling pathway ultimately
creating proteins (Goldfarb, 2001). Tyrosine phosphorylation is an essential reaction in cell differentiation,
the cell cycle, signal transduction and gene regulation and transcription (Abel et al., 2012; Meijer et al.,
1991; Lin et al., 2006). If a mutation caused an FGF protein to be non-functional, tyrosine phosphorylation
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may not be activated and potentially affecting protein synthesis, which in turn could affect immune
response.
Another candidate gene showing favorable results was MAP1A (microtubule-associated protein
1A) with a 97.5% SNP (G base) frequency in the AR line (matching reference base) and a 60% SNP (A
base) frequency in the AP line. This gene was found to have high cytoplasmic expression in humans with
gliomas (Meyer, 2014) and MAP1A mRNA affected tumor size in rats when delivered straight into the
tumor via a mini-osmotic pump (Matsuno et al., 2004). Meyer’s (2014) results indicate that MAP1A may
have a connection to tumor development and growth, making it a potential gene involved in the
development of RSV-induced tumors in the AR and AP chicken lines.
POU6F2 (POU class 6 homeobox 2) SNP frequencies were 100% divergent in the AP line (T
base- same as reference) and AR line (C base). This gene is a member of the POU family, which are
transcriptional regulators and help control cell type specific differentiation pathways. This gene has been
identified as a tumor suppressor involved in Wilm Tumor (WT) hereditary predisposition (RefSeq, 2009;
Perotti et al., 2004). Since this gene has already been identified as a tumor suppressor gene in humans, it
is possible that it has the same function in chickens since the genomes are similar. This SNP is also
located in an intron, but as mentioned with FGF 14, an introgenic mutation can affect gene expression.
Lastly, NCK2 (NCK adaptor protein 2), has a 100% SNP (A base) frequency for AR line and a
100% SNP (T base) frequency for AP line with AP matching the reference base. This gene is also located
on an intron. NCK2 is involved in cell signaling, proliferation, cytoskeleton organization, and stress
response. This gene is known to promote human melanoma cell proliferation, migration and invasion in
melanoma-derived tumor growth. When injected with overexpressed human primary melanoma cells,
mice experienced increased melanoma-derived tumor growth, indicating NCK2 can influence human
melanoma phenotype (Labelle-Cote et al., 2011). Again, with the human and chicken genome containing
60% of corresponding genes, NCK2 could be a potential biomarker for tumor growth.
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Phenotypic Results
Phenotypic differences in tumor development caused by RSV inoculation were depicted by a
tumor score system (Figures 3-9). The results for the AR line, shown in Figure 10, confirm the line’s ability
to regress tumors over time compared to the tumor progression exhibited by the AP line (Figure 11). The
AR line had a much quicker response to RSV than that of AP. On day 28, the average tumor score was
2.8 and then quickly dropped down to less than 1 by 40 days post inoculation (dpi). At the end of the trail,
the average tumor score for AR was 1.125, which is about the size of a BB bullet. This phenotype was
expected for the AR line. As shown in figure 11, the AP line does not show any signs of large tumors until
day 28dpi. On this day, the average tumor score jumped to about 3, which is the size of a marble. On day
32dpi, the average tumor score drops to approximately 2, but then gradually increases to 4.25, the size of
a ping pong ball. The gradual increase over time was expected for the AP line as they were selected for
tumor progression. The difference between the average tumor scores at the end of the trial was
significantly different, with a 95% Confidence Interval. The genotype-phenotype correlations for the AR
and AP line were further tested in unrelated populations, discussed in Chapter 4.
CONCLUSION
One of the main objectives of this study was to link the phenotype of tumor progression and
regression to specific genotypes, in this case SNPs. Whole genome sequencing was performed to
identify SNPs that contribute to RSV induced tumors. Nine candidate SNPs, located in intron and exon
regions, were identified to be potential biomarkers associated with RSV induced tumors. Sequencing
results showed high divergence in point mutations between the AP and AR lines. The next step is to
validate the candidate SNPs in unrelated populations. Identifying functional variants in the genome can
be used in marker-assisted selection for performance improvement in farm livestock. Associations with
functional variants can also be utilized for disease biology and pharmacology.
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LEGEND OF TABLES AND FIGURES

Table 1: Primer sets for 9 candidate biomarkers
Candidate SNPs had a forward, reverse, and sequencing primer. This table includes the SNP
location, GC% content, annealing temperature and product size for each candidate biomarker.
Table 2: Tumor Sizing Scale
Table 3: Sequencing Results for larger AP and AR populations
SNP frequencies for each candidate are listed as well as the type of mutation, genotype, feature,
and impact. SNP frequencies are listed as SNP % of called base in this table. The lowest SNP
frequency of the candidate biomarkers was MAP1A at 60% SNP frequency.
Figure 1: PCR 96 well plate format for AP and AR lines
Top four rows contained AR samples and bottom four rows contained AP samples. A 96-well
plate with this set up was used for each primer set. The order of DNA samples remained the
same for each PCR.
Figure 2: Sample pooling for PCR purification and sequencing
Four different primer sets and 8µl from each sample pooled into one 96-well plate totaling 32µl of
4 different PCR products. After PCR purification, each well contained 100µl of pooled DNA. Then
3µl of all samples in each row were pooled into one well. For example, 3µl of all samples in row A
are pooled into one tube.
Figures 3-9: Photos of each tumor score shown as examples for each score 1-6
Figure 10: Average tumor scores for AP and AR chickens with Standard Error
Average tumors scores over time are shown. The y-axis represents the tumor score and the xaxis represents the number of days post inoculation. It is shown that the average tumor scores
increased over time and did not regress for the AP chickens. It is shown that the average tumor
scores increased at about 28 days post inoculation, but then decreased shortly after and
remaining the same for the AR chickens.
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Table 1: Primer sets for 9 candidate biomarkers
SNP
location
(Chr:bp)
1:134690198

Feature
name
NCK2

2:50117844

POUF6

1:3380404

IL2RA

18:6611691

ATAD5

21:4919322

CASP9

1:142233297

FGF14

2:50469650

CDK13

10:11603087

IL16

10:19701184

MAP1A

Primer name

Primer sequences

GC%

Tm
(°C)

NCK2_1_F
NCK2_1_R
NCK2_Seq_F_1
POUF6_1_F
POUF6_1_R
POUF6_Seq_1_F
IL2RA_1_F
IL2RA_1_R
IL2RA_1_SEQ_F
ATAD5_1_F
ATAD5_1_R
ATAD5_1_SEQ_F
CASP9_1_F
CASP9_1_R
CASP9_Seq_F
FGF14_F_1
FGF14_R_1
FGF14_Seq_1
CDK13_F_1
CDK13_R_1
CDK13_Seq_1
IL16_F_1
IL16_R_1
IL16_Seq_1
MAP1A_F_1
MAP1A_R_1
MAP1A_Seq_1

caggtccttagctgctttctgt
acaggaaagctgatgggattta
actccagcaagctgttgatcct
gacctctgtctctgaaagtagc
tttggcatcagactccaacacc
gcttctacacattctgtcttgg
tcctgaaccccaagcaggtttt
acaaagcagcacgttgttaggc
cttaggttgttcctgtgttggc
ggttttcctgaaccttgctacg
cacgtactggacaagcaccaaa
caaggtggttcaagaacttcag
ttctcgttccctccttctgtct
aaaaccaggacttcgcagccta
agttggttgttgccaacactgc
gttaacacctgcaggctcacca
gtacaggtcgtacaatccttac
aatggcacttgtgtctgcctg
gggcactgcctttcctattttg
tgtactgctcgtaggagaaggt
gaaacaggcgatcagcaaaatc
tggttgcttcctgctcttgatg
acacttaacgcgtctcagcatt
ggaaacaggacacttctgctaa
aggagatgccatcttgactgtg
agtgaacagcatgccttcctct
tcagcctctgcagagtcaacct

50
40.91
50
50
50
45
50
50
50
50
50
45
50
50
50
55
45
50
50
50
45
50
45
45
50
50
55

60.07
59.97
54.8
54.8
54.8
53
54.8
54.8
54.8
54.8
54.8
53
54.8
54.8
54.8
56.7
53
54.8
54.8
54.8
53
54.8
53
53
54.8
54.8
56.7

Table 2: Tumor Sizing Scale
Tumor Score

2

Size Range (cm )

Subjective Score

0

0

No tumor

1

0.1 – 0.25

BB

2

0.25 – 1.0

Pea

3

1.0 – 4.0

Marble

4

4.0 – 9.0

Ping pong ball

5

9.0 – 16.0

Golf ball

6

16.0 and greater

Egg

50

Product
size
(bp)
471

485

476

462

434

520

448

510

451

Table 3: Sequencing Results for larger AP and AR populations

51

Gene

Line

Chr

Ref
Position

Ref
Base

IL16

AP

10

11603087

T

FGF14

AP

1

142233298

T

IL2RA

AP

1

3380404

C

MAP1A

AR

10

19701184

G

CDK13

AR

2

50496950

ATAD5

AR

18

CASP9

AR

POU6F2
NCK2

Mutation
Nonsynonymous
Non-coding
region

Called
Base

Expecte
d Base

SNP % of
called
base

Genotype

Feature

C

C

100% C

Homo. Var

CDS

C

C

100% C

Homo. Var

gene

T

T

100% T

Homo. Var

CDS

A:G

A

60% A

Hetero. Var

CDS

G

Silent
Nonsynonymous
Nonsynonymous

A

A

100% A

Homo. Var

CDS

6611691

C

Stop codon

T:C

T

83% T

Hetero. Var

CDS

21

4919322

G

A:T

A

83% A

Hetero. Var

CDS

AR

2

50117844

T

C

C

100%

Homo. Var

gene

AR

1

134690198

T

Nonsense
Non-coding
region
Non-coding
region

A

A

100%

Homo. Var

gene

Impact
Ile to Thr (ATT
-> ACT)

Ile to Ile (ATC>ATT)
Gly to Arg
(GGA->AGA)
Thrto Thr
(ACG->ACA)
Gln to stop
(CAG->TAG)
Cys to stop
(TGC->TAG)

Figure 1: 96-format for AP and AR lines

Rows A-D - AR
genomic DNA
samples

Rows E-H - AP
genomic DNA
samples

PCR for each set of primers (forward and reverse)

Top four rows- PCR
products for AR line

Bottom four rowsPCR products for AP
line

52

Figure 2: Sample pooling for PCR purification and sequencing.
* Note: each well represents the same sample/same bird in each plate.

8µl each sample

8µl each sample

8µl each sample

Each well has 32µl DNA

DNA Clean Up using Promega
Wizard SV DNA Clean Up Kit
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8µl each sample

Figure 2 cont’d: Each tube displayed below represents a row with a specific sequencing
primer

3µl of each
sample in row A

Seq primer 1

3µl of each
sample in row A

3µl of each
sample in row A

Seq primer2

Seq primer 3

3µl of each
sample in row A

Seq primer 4

Each tube contains 1.5µl sequencing primer, 20ng DNA, and distilled water to a total volume of 13µl.
Each set of 8 tubes contain the same DNA but have different primers in order to sequence different
PCR products in the pooled samples. Samples are then submitted for sequencing to the DNA Core Lab.
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Figure 3: Wing web without tumor

Figure 4: Tumor with score of 1 (BB size)
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Figure 5: Tumor with score of 2 (pea size)

Figure 6: Tumor with score of 3 (marble size)
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Figure 7: Tumor with score of 4 (ping pong ball size)

Figure 8: Tumor with score of 5 (golf ball size)
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Figure 9: Tumors with score of 6 (anything larger than a golf ball and has
coloration and/or fluid oozing)
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Figure 10: Average tumor scores for AP and AR chickens
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CHAPTER 4: APPLICATION OF CANDIDATE GENETIC MARKERS IN GIANT JUNGLE FOWL AND
WHITE LEGHORN POPULATIONS
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INTRODUCTION
Studies to identify genetic markers for regression and progression from RSV-induced tumors
have been performed in the past (Spanakos, 2007). Many results point to the MHC region (B-complex) of
having the most indicative loci for tumor regression and progression. Spanakos (2007) found four loci
within the B-complex associated with tumor response induced by RSV; the Ea-A, Ea-C, Ea-I and Y loci.
4

5

13

13

2

2 2 8

1.1

7

Different haplotpyes were investigated and the A A B B C C I I Y Y haplotype was determined to
13

13

be the most progressive of birds with the B B genotype. A structural analysis of MHC alleles in RSV
tumor regression chickens using a BAC library uncovered great genetic diversity. The BLB2 gene,
encoding the MHC class II beta chain, had 19 non-synonymous SNPs; however, a comparison of WLA
(RSV tumor regressive allele) and B6 haplotypes associated with tumor regression revealed that the
BLB2 gene was not indicative of tumor regression intensity (Suzuki et.al., 2012). While the MHC region in
the chicken genome plays an important role in the immune response to RSV, there is evidence showing
non-MHC loci are also involved. Birds with the MHC genotypes found to be susceptible to RSV have
been observed to regress tumors, while some birds with resistant genotypes succumb to RSV. Certain
combinations of haplotypes could be the underlying cause of regression or progression of RSV-induced
tumors.
In this study, nine different SNPs were identified as being potential biomarkers associated with
RSV induced tumors in chickens and then validated for degree of divergence in the AR and AP lines. The
high SNP frequency differences between the two lines showed significant differences, indicating the need
to test the genotype-phenotype correlation. The Giant Jungle Fowl (GJF) and White Leghorn (WL) lines
were chosen as the unrelated populations to validate the association of the potential genetic markers to
tumor growth after RSV infection. Candidate SNPs were validated in each line to correlate the
phenotypes and genotypes to tumors developed from RSV. Genotypic and phenotypic data was sampled
and analyzed to find such correlations. In this study, it was hypothesized that the GJF population would
have a higher percentage of regression over progression since the AR line was derived from this breed.
The WL population was hypothesized to have a higher percentage of progression, but not higher than the
AP line established at the University of Arkansas. The AP line was derived from a cross between GJF and
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WL chickens, thus the WL line is more similar to the AP line genetically. In this chapter, the nine potential
SNP biomarkers identified by genome sequencing and validation studies of the AP and AR chicken lines
were examined to determine whether the chosen SNPs are associated with RSV-induced tumor
progression and regression in the two unrelated populations GJF and WL.
MATERIALS AND METHODS
Genetic Lines
Two unrelated populations of chicken lines, GFJ and WL, were utilized to determine SNP
frequencies in this study. The GJF line is theorized to be highly inbred as its origins stem from one male
and five hens from Southeast Asia in 1951 (Gyles et al., 1966). This strain has been maintained at the
AES since 1951 as a small closed flock. The original WL strain used to create the AP line is no longer
being maintained at the AES, thus a commercial WL population from Kimbrough Farms in Neosho, MO
was used as the other unrelated chicken population.
DNA sampling and preparation
Whole blood was collected from the GJF and WL lines via wing web puncture from more than 100
birds at two weeks of age. Approximately 2-3 drops (100-200µL) of blood was collected and stored in
tubes containing 100µl sodium citrate (C6H8O7) to prevent clotting. Genomic DNA was extracted into a 96
well format using the Wizard SV 96 Genomic DNA Purification System (Promega; Madison, WI) following
manufacturer’s instructions with some modifications. Whole blood (10µL) was thoroughly mixed with
proteinase K (6.7µL/µL) and incubated at room temperature for 10 minutes. The lysis buffer (300µL) was
and triton X-300 (33µL) was missed with RNase A (55µL) in a single boat. This mixture was added to the
blood/proteinase K mixture and blood clots were dissociated by repetitive pipetting. Once blood clots
were dissociated, a vacuum manifold system was used to filter lysate through filters of the binding plate.
Three consecutive cycles of ethanol washing was applied followed by elution with nuclease- free water
(200µL). Extracted DNA concentration was quantified using NanoDrop 1000 spectrophotometer (Thermo
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Fisher Scientific Inc.; Waltham, MA). For all samples, a 1ng/µL dilution was prepared in empty 96 well
plates for PCR and used as an aliquot.
PCR
For GJF and WL lines, tumor scores were analyzed and birds with more extreme tumor
progression or regression were used for SNP validation in the unrelated populations. The GJF line had 50
out of 96 samples representing tumor regression, or tumor resistance (RES) and 34 out of 96 samples
representing tumor progression, or tumor susceptibility (SUS). The 50 RES and 34 SUS samples were
pooled to create two pooled samples representing both phenotypes. The WL line had 27 RES samples
and 21 SUS samples, which were pooled to represent one sample for each phenotype. PCR was
performed for each of the nine candidate genes for GJF and WL lines, resulting in 18 different PCR
reactions for each line. The same primer sets used in Chapter 3 were used for GJF and WL PCR
reactions. Total reaction volume was 25µL: 5µL DNA (1ng/µL), 2.5µL 10x buffer, 1µL 2.5mM dNTP mix,
2µL F primer, 2µL R primer, 0.5µL Taq DNA Polymerase (NEB, Ipswich, MA). PCR conditions were as
follows: denaturation at 95ºC for 1 min, 40 cycles of amplification (95ºC for 30 sec, 60ºC for 1 min, 72ºC
for 1 min), and a final extension at 72ºC for 10 min. PCR assays were performed using Applied
Biosystems 2720 Thermal Cycler (Life Technologies, Carlsbad, CA). The quality and validation of PCR
product was performed by 1% agarose gel electrophoresis.
Gel Electrophoresis
From each PCR product, 5µL was mixed with 6x loading dye, which contained bromophenol blue
and xylene cyanol dyes. The mixtures were loaded into wells of a 1% agarose gel prepared with 1x TAE
buffer solution. The first well was loaded with 5µL Hi-Lo DNA molecular weight marker (Bionexus, Inc.,
Oakland, CA) to confirm the PCR product size. A Bio-Rad Gel Doc XR imaging system (Bio-Rad
Laboratories, Hercules, CA) was used for gel imaging.
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PCR product purification
After gel electrophoresis, PCR product was purified using the Illustra GFX PCR DNA purification
kit (GE Healthcare Life Sciences, Pittsburg, PA) following manufacturer’s protocol. Membrane-binding
solution (100µL) was added to the pooled PCR products were centrifuged at 10,000X. Washing buffer
was applied to the samples and then eluted with 30µL nuclease-free water. The concentrations of purified
DNA were quantified using NanoDrop 1000.
Sanger Sequencing
To prepare the purified PCR products for sequencing, pooled DNA with concentration 10ng/µl,
diluted with distilled water, was mixed with 4-5µl of the sequencing primers with concentration 1.6uM.
Sequencing was performed at the University of Arkansas for Medical Sciences (UAMS) in Little Rock,
Arkansas. Sequencing results were analyzed with Sequence Scanner software v.1 (Applied Biosystems
of Thermo Fisher, Waltham, MA). Peak heights at SNP locations were examined and the ratios of
different bases at the SNP location were recorded and analyzed.
RSV Inoculation and blood collection
The bird populations being tested were also observed for phenotypic data collection.
Approximately 100 birds from each line were hatched and maintained at the AES (Fayetteville, Arkansas).
To produce the GJF birds for this study, matings were achieved via artificial insemination using pooled
semen of at least 10 males or more. At hatch, all chicks were given a wing band with a unique identifying
number and then placed randomly in pens, where feed and water were provided ad libitum during growout of the birds. Tumor scores were recorded for each bird/wing band about every 3 days.
All birds were inoculated subcutaneously with 70pfu Bryan high-titer strain Rous Sarcoma Virus
(0.1mL) in the wing web at six weeks of age. RSV-induced tumors were examined three times a week
and recorded for 8-10 weeks post inoculation to tumor progression and regression. The same sizing scale
described in Chapter 3 was used for recording tumor scores. Images of example tumor sizes can be
reviewed in Chapter 3, Figures 3-9.
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Once a tumor reached a score of 5 for one week, and showed no sign of regression, the bird was
humanely euthanized. Also, if the skin covering the tumor broke open, and the contents were visible
outside the tumor, the bird was humanely euthanized. All birds were humanely euthanized 10 weeks post
inoculation by CO2 (Guidelines for Euthanasia for Poultry, American Veterinary Medical Association).
RESULTS AND DISCUSSION
The GJF and WL lines were used to determine whether the candidate SNPs would diverge
relative to tumor incidence. Roughly 100 birds from each line were inoculated with RSV. In the GJF and
WL lines, the most tumor resistant (RES) and tumor susceptible (SUS) birds were separated by
phenotype and then pooled to determine approximate allele frequencies before testing individual SNPs.
RES was classified as having a tumor reach a score of at least 3 or more and then regress to either a 1 or
0 for the last 3 consecutive scorings. SUS was classified as having a tumor develop and reach a score of
at least 4 and remain at that score or higher. The GJF line had 50 RES samples pooled and 34 SUS
samples pooled, totaling 84 samples. GJF RES and SUS birds represented 52% and 35%, respectively,
of the entire GJF population tested (96 samples). The WL line had 27 RES samples pooled and 21 SUS
samples pooled, representing 28% and 21%, respectively, of the entire WL population (96 samples).
Overall, the sequencing results showed no significant differences at the SNP locations between the
resistant (RES) and susceptible (SUS) birds within GJF and WL lines; however, there were SNPs which
were divergent between the GJF and WL lines (Table 1).
The GJF line was derived from an unselected Giant Jungle Fowl population in Southeast Asia,
the natural range of the Red Jungle Fowl (RJF) (Storey et al., 2012). Using DNA fingerprinting, GJF, also
known as the Domestic Jungle Fowl, has been theorized to be more closely related to RJF than White
Leghorn strains (Seigel, P.B. et al., 1992), thus its genome should be genetically more similar to the RJF
genome than that of the WL line. GJF and WL showed means 33% and 60% differences to RJF for all
tested SNPs; respectively, thus the WL line was expected to be more susceptible to RSV-induced tumor
development since the GJF line is more regressive and more closely related to the RJF. The grand mean
tumor score for GJF was 1.44 with a variance of 0.48 and the grand mean tumor score for WL was 2.92
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with a variance of 0.33. An unpaired t-test showed a two-tailed p value of less than 0.00001 with a
significance level (p-value) of 0.05, indicating a significant difference between the grand mean tumor
scores for GJF and WL. The divergent SNPs between GJF and WL lines could be evidence of humandriven selection based on a phenotypic trait. For IL2RA, WL had a 100% SNP frequency (T base),
differing from GJF and RJF (C base). There was also a 100% SNP frequency (A base) seen for WL
NCK2, while GJF had a SNP frequency (A base) of 14% and 9% for resistant and susceptible birds,
respectively. In the GJF line, SNPs in genes CASP9 and IL16 had no genetic difference to RJF and a
50% difference in SNPs housed in POU6F2, MAP1A, FGF14, and ATAD1. The WL line showed no
genetic difference to RJF for FGF14 and MAP1A and 100% difference to RJF in POU6F2 and ATAD1.
SNP frequencies for WL CDK13, IL16, CASP 9, and ATAD1 were 50%, 20%, 67%, and 92% respectively
(Table 1).
Potential correlations associated with tumor progression and regression based on the chosen
SNPs could not be analyzed since there were no genotypic differences between birds of differing
phenotypes within the GJF or WL lines. All RES and SUS birds within each population had the same
SNP frequencies. There were two SNPs which did show some differences between the tumor RES and
SUS birds in the GJF lines. GJF NCK2 had a 5% difference between RES and SUS birds and GJF
CDK13 had a 6% difference between RES and SUS birds. Chi-square analysis was performed and
results showed no significant difference in either SNP (p=0.3566 for NCK2 and p=0.2488 for CDK13). A
chi-square analysis could not be performed on any other SNP frequencies because all individuals within a
population shared the same SNP frequency.
The GJF and WL lines represented two un-related populations to AP and AR and were not to be
compared to each other. The genetic variation of the SNP locations in GJF and WL lines was not of
interest in this study; however, it did not go unnoticed. There was no correlation between the phenotype
and genotype of birds within a population. It is possible that during intense selection of AP and AR lines,
genetic drift of the SNPs of interest became fixed, resulting in different genotypic combinations without
causing phenotypic changes. Artificially selecting individuals could increase the chance of genetic drift,
especially when only the phenotype is used as the selected trait. Limited gene flow and genetic drift in a
66

finite sub-divided population could potentially cause linkage disequilibrium, making it difficult to identify
direct genotype-phenotype correlations (Ohta, 1982). The high frequency SNPs that are highly divergent
from the reference do show evidence of genetic variation caused by selection. In order to find haplotype
combinations related to tumor incidence caused by RSV, an analysis of variance could be performed for
birds showing genetic differences within larger population.
In this chapter, nine candidate genetic markers were evaluated in GJF and WL populations,
representing two populations un-related to the AP and AR lines. GJF and WL populations were
challenged with RSV and then genotyped at the candidate SNP loci to identify any association to
phenotypic change. No statistical significance was found between phenotypes within each line. The only
SNP differences found were between the GJF and WL, which could be evidence of chicken domestication
since the GJF is more closely related to RJF. The WL line has been selected for egg-laying performance
and thus, more genetic drift caused by bottlenecking is likely. The GJF showed 33% difference from RJF
at the nine SNP locations while WL showed 56% difference. To determine whether domestication is
exhibited at the nine SNP locations, a larger sample size would need to be studied.
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LEGEND OF TABLES AND FIGURES
Table 1: Frequencies for each candidate SNP for RES and SUS in GJF and WL lines
Observed SNP frequencies are listed for RES and SUS birds for both un-related chicken lines
(GJF and WL). SNP frequency differences are listed between RES and SUS birds, between
GJF/WL and RJF, and between GJF and WL
Figure 1: GJF and WL Average Tumor Scores with Standard Error

Average tumor scores for GJF and WL population (96 samples) with moving average trendline
and standard error.

69

Table 1: Frequencies for each candidate SNP for RES and SUS in GJF and WL lines
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Gene
ATAD1
ATAD1
CASP9
CASP9
CDK13
CDK13
FGF14
FGF14
IL2RA
IL2RA
IL16
IL16
MAP1A
MAP1A
NCK2
NCK2
POU6F2
POU6F2

Ref
C
C
G
G
G
G
T
T
C
C
T
T
G
G
T
T
T
T

Pheno
RES
SUS
RES
SUS
RES
SUS
RES
SUS
RES
SUS
RES
SUS
RES
SUS
RES
SUS
RES
SUS

GJF
C/T
C/T
G
G
A/G
A/G
C/T
C/T
C
C
T
T
G/A
G/A
T/A
T/A
T/C
T/C

GJF ratio
1:1
1:1
1:0
1:0
5:1
8:1
1:1
1:1
1:0
1:0
1:0
1:0
1:1
1:1
7:1
10:1
1:1
1:1

SNP freq
0.50
0.50
0.00
0.00
0.83
0.89
0.50
0.50
0.00
0.00
0.00
0.00
0.50
0.50
0.14
0.09
0.50
0.50

% diff to ref
0.50
0.50
0.00
0.00
0.83
0.89
0.50
0.50
0.00
0.00
0.00
0.00
0.50
0.50
0.14
0.09
0.50
0.50

WL
T/A
T/A
A/G
A/G
A/G
A/G
T
T
T
T
T/C
T/C
G
G
A
A
C
C

WL ratio
12:1
12:1
2:1
2:1
1:1
1:1
1:0
1:0
0:1
0:1
4:1
4:1
1:0
1:0
0:1
0:1
0:1
0:1

SNP freq
0.92
0.92
0.67
0.67
0.50
0.50
0.00
0.00
1.00
1.00
0.20
0.20
0.00
0.00
1.00
1.00
1.00
1.00

% diff to ref
1.00
1.00
0.67
0.67
0.5
0.5
0.00
0.00
1.00
1.00
0.20
0.20
0.00
0.00
1.00
1.00
1.00
1.00

% diff b/w lines
0.42
0.42
0.67
0.67
0.33
0.39
0.50
0.50
1.00
1.00
0.20
0.20
0.50
0.50
0.91
0.91
0.50
0.50

Figure 1: GJF and WL Average Tumor Scores with a 2 per. Mov. Avg
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CONCLUSION
Poultry is a key organism in genetic research due to breeding feasibility, relatively short
generation periods and distinct phenotypes. In addition, poultry experimental populations serve as models
in base and applied biomedical studies for human disease. In addition, recent development of new
sequencing technologies enables vertebrate genomes to be sequenced more efficiently. Hence, genome
sequencing of commercial and experimental chicken lines can provide insight into the genetic correlates
of phenotypic changes. Whole genome sequencing can improve the understanding of poultry diversity,
provide a tool for the use of genome-wide marker assisted selection to enhance genetic gain in
commercial stock, yield knowledge of genetic diagnostics to detect predisposition of genetic disorders,
and can support characterization of potential biological mechanisms of genetic disease.
Genetic correlations between specific genotypes to phenotypic traits can increase heritability in a
population. Increased heritability can enable rapid change under selection pressures for traits of interest.
Genomic data can provide the poultry and biomedical industries biomarkers which can be used in animal
breeding programs and prognosis of certain disease in human medicine. One type of biomarker is a
single nucleotide polymorphism (SNP) and has been widely used for its ease of detection. Application of
next generation sequencing to agricultural and biomedical chicken populations can identify SNPs
associated with important phenotypic traits.
Genetic lines representing tumor progression (AP) and regression (AR) after inoculation of rous
sarcoma virus (RSV) have been established and maintained by N. B. Anthony at the University of
Arkansas. Genomes for AP and AR lines were sequenced and then aligned with reference genome Red
Jungle Fowl. Unique SNPs were identified in AP and AR lines to be potential indicators associated with
progression or regression of RSV-induced tumors. Over 7 million SNPs were filtered based on frequency,
location, read depth, and gene function. A total of 9 candidate SNPs, 4 for AP and 5 for AR, were chosen
as candidate biomarkers associated with RSV tumor growth.
Genomic sequencing results were based on 10 pooled DNA samples for each line; therefore
SNPs were validated in larger populations of 96 per line. SNPs showing high frequency differences
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between AP and AR lines were compared, and those with highest divergence were considered for further
validation. Genotyping results showed SNPs SNPs between AP and AR lines were at least 60% or more
divergent. The average SNP frequency for all 9 candidates was 92%, meaning the AP and AR lines were
92% different when considering all 9 SNP locations.
To investigate any genotype-phenotype associations, two un-related populations were challenged
with RSV and genotyped at the 9 SNP locations. The two un-related populations used were the Giant
jungle fowl (GJF) and White Leghorn (WL). Birds within each line were grouped based on phenotype RES
or SUS, where RES birds are those whose tumors regressed completely and SUS birds were those
whose tumors progressed drastically. The RES and SUS groups for GJF and WL lines were genotyped.
There was no significant difference found between RES and SUS birds in either chicken line. SNP
frequencies between RES and SUS birds were almost identical, showing no genotypic correlation to the
phenotypic trait of interest. Because the AP and AR lines have been intensely selected based on one
phenotype, genetic drift caused from bottlenecking could have segregated the alleles at the 9 SNP
locations studied. Further testing with a larger number of candidate SNPs in larger populations could
reveal sets of haplotypes associated with tumor destiny.
Although no SNP differences were detected between RES and SUS birds within each line, there
was a significant difference (p=0.0001) detected for grand mean tumor score between the GJF and WL
lines. The RJF is theorized to be the ancestral bird of all chicken breeds. The SNP differences between
GJF and WL lines could be evidence of domestication as GJF is more closely related to RJF than WL.
GJF showed a grand mean 33% difference to RJF based on the 9 SNPs and WL showed a grand mean
60% difference to RJF based on the 9 SNPs. To further tests these SNPs for evidence as chicken
domestication, larger samples sizes and additional chicken breeds would need to be used.
The AR and AP lines have been heavily selected for 60 years or more, which would explain the
complete genetic divergence between the two lines. The GJF population has most likely experienced
strong random genetic drift due to random selection while maintained at the AES. With over 12,000
unique SNPs found between the AR and AP lines, there are a large number of haplotype combinations
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that could be responsible for the response to Rous sarcoma virus in chickens. Only nine out of that
12,000 were chosen as candidate biomarkers based on gene function and SNP frequency. There are
many more opportunities to continue studying the genotype-phenotype relationship associated with RSVinduced tumors.
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